FindTrial
Sign In

A Study of Infections, Antibiotic Prescription And Survival Rate Among Head And Neck Cancer Patients

Assessment of Infections, Antimicrobial Prescription Pattern And Survival Rate Among The Head And Neck Cancer Patients: A Retrospective Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071485
Enrollment
369
Registered
2024-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx Health Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)All advanced stage HNC patients who are 18 years and above and were treated in the last 5 years in Justice KS Hegde Charitable Hospital 2)Cade sheets containing complete information of HNC patients 3)Patients who have received chemo radiation or radiotherapy

Exclusion criteria

Exclusion criteria: 1)Participants with incomplete data in case files 2)Participants or caregivers who do not respond to phone calls

Design outcomes

Primary

MeasureTime frame
This study will provide a summary of prescription pattern of antimicrobial agents, prevalence of infections, antimicrobial resistance and survival status of the Head and Neck Cancer patients.Timepoint: 8 months—

Secondary

MeasureTime frame
Infection will be correlated with the mortality among Head and Neck CancerTimepoint: 8 months—

Countries

India

Contacts

Public ContactDr Krishna Sharan

NGSM Institute of Pharmaceutical Sciences

udayv@nitte.edu.in8152977460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026